newsfilter
← Latest News
Business Wire·

Silence Therapeutics to Participate in September Investor Conferences

Silence Therapeutics plc, Nasdaq: SLN ("Silence" or the "Company"), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced that management will participate in the